RecruitingNCT06954727

China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization

China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-A Quality Control on Right Heart Catheterization


Sponsor

China-Japan Friendship Hospital

Enrollment

10,000 participants

Start Date

Jan 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Right heart catheterization(RHC) plays a crucial role in the diagnosis and treatment of pulmonary vascular diseases(PVD). In China, the lack of equipment and technical expertise has historically limited the implementation of RHC, thereby greatly restricting the diagnosis and treatment of RVD. In recent years, with improvements in these issues, more hospitals have acquired the capability to perform RHC. The purpose of this study is to conduct quality control of RHC across multiple pulmonary hypertension(PH) centers in China. The study population consists of patients who underwent RHC for the first time due to dyspnea or suspected PH. This study retrospectively and prospectively collects multicenter RHC data, with the main quality control contents including indications for the procedure, collection and analysis of hemodynamic data, diagnosis and treatment, and long-term management of patients.


Eligibility

Min Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This study builds a registry of patients in China who undergo a procedure called right heart catheterization — a test where a thin tube is inserted into the heart's right side to measure blood pressure in the lungs — to better understand pulmonary hypertension (high blood pressure in the lungs) and related vascular diseases. The goal is to improve diagnosis and treatment across China. **You may be eligible if...** - You are 14 years or older - You are undergoing a right heart catheterization for the first time because of shortness of breath or suspected pulmonary hypertension **You may NOT be eligible if...** - Important health data about you is missing - You did not sign informed consent or do not agree to follow-up Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention; Observational study

No intervention; observational study


Locations(1)

China-Japan Friendship Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06954727


Related Trials